161 related articles for article (PubMed ID: 8167350)
41. Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders.
Limaye AP; Huang ML; Atienza EE; Ferrenberg JM; Corey L
J Clin Microbiol; 1999 Apr; 37(4):1113-6. PubMed ID: 10074534
[TBL] [Abstract][Full Text] [Related]
42. Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children.
Green M; Bueno J; Rowe D; Mazariegos G; Qu L; Abu-Almagd K; Reyes J
Transplantation; 2000 Aug; 70(4):593-6. PubMed ID: 10972215
[TBL] [Abstract][Full Text] [Related]
43. Monitoring of Epstein-Barr virus load and antibody in pediatric renal transplant patients.
Sato T; Fujieda M; Tanaka E; Miyamura M; Chikamoto H; Hisano M; Akioka Y; Ishiura Y; Dohno S; Maeda A; Hattori M; Wakiguchi H
Pediatr Int; 2008 Aug; 50(4):454-8. PubMed ID: 19143966
[TBL] [Abstract][Full Text] [Related]
44. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
[TBL] [Abstract][Full Text] [Related]
45. Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.
Stevens SJ; Verschuuren EA; Verkuujlen SA; Van Den Brule AJ; Meijer CJ; Middeldorp JM
Leuk Lymphoma; 2002 Apr; 43(4):831-40. PubMed ID: 12153173
[TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort study.
Parrish A; Fenchel M; Storch GA; Buller R; Mason S; Williams N; Ikle D; Conrad C; Faro A; Goldfarb S; Hayes D; Melicoff-Portillo E; Schecter M; Visner G; Sweet S; Danziger-Isakov L;
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28639398
[TBL] [Abstract][Full Text] [Related]
47. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
[TBL] [Abstract][Full Text] [Related]
48. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.
Jabs WJ; Hennig H; Kittel M; Pethig K; Smets F; Bucsky P; Kirchner H; Wagner HJ
J Clin Microbiol; 2001 Feb; 39(2):564-9. PubMed ID: 11158107
[TBL] [Abstract][Full Text] [Related]
49. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients.
Stevens SJ; Verschuuren EA; Pronk I; van Der Bij W; Harmsen MC; The TH; Meijer CJ; van Den Brule AJ; Middeldorp JM
Blood; 2001 Mar; 97(5):1165-71. PubMed ID: 11222357
[TBL] [Abstract][Full Text] [Related]
50. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
[TBL] [Abstract][Full Text] [Related]
52. A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events.
Haque T; Thomas JA; Parratt R; Hunt BJ; Yacoub MH; Crawford DH
Transplantation; 1997 Oct; 64(7):1028-34. PubMed ID: 9381525
[TBL] [Abstract][Full Text] [Related]
53. Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation.
Jang JY; Kim KM; Lee YJ; Lee SG; Chi HS
Transplant Proc; 2008 Oct; 40(8):2546-8. PubMed ID: 18929796
[TBL] [Abstract][Full Text] [Related]
54. Comparison of immortalization assay and polymerase chain reaction detection of Epstein-Barr virus in pediatric transplant recipients and control samples.
Salimi B; Alonso EM; Cohn RA; Mendley SR; Katz BZ
Pediatr Pathol Mol Med; 2002; 21(4):433-43. PubMed ID: 12092707
[TBL] [Abstract][Full Text] [Related]
55. Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder.
Lager DJ; Slagel DD; Burgart LJ
Arch Pathol Lab Med; 1993 Mar; 117(3):308-12. PubMed ID: 8382918
[TBL] [Abstract][Full Text] [Related]
56. Long-lasting chronic high load carriage of Epstein-Barr virus is more common in young pediatric renal transplant recipients.
Ladfors SW; Lindahl JK; Hansson S; Brandström P; Andersson R; Jertborn M; Lindh M; Woxenius S; Friman V
Pediatr Nephrol; 2020 Mar; 35(3):427-439. PubMed ID: 31802220
[TBL] [Abstract][Full Text] [Related]
57. T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
Kuno M; Ito A; Maeshima AM; Taniguchi H; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
Int J Hematol; 2020 Aug; 112(2):193-199. PubMed ID: 32472530
[TBL] [Abstract][Full Text] [Related]
58. Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients.
Orentas RJ; Schauer DW; Ellis FW; Walczak J; Casper JT; Margolis DA
Pediatr Transplant; 2003 Aug; 7(4):305-14. PubMed ID: 12890010
[TBL] [Abstract][Full Text] [Related]
59. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL
J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
[TBL] [Abstract][Full Text] [Related]
60. Detection of Epstein-Barr virus by polymerase chain reaction.
Telenti A; Marshall WF; Smith TF
J Clin Microbiol; 1990 Oct; 28(10):2187-90. PubMed ID: 2172284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]